KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Paylocity Holding (PCTY) Cash & Equivalents (2016 - 2025)

Paylocity Holding has reported Cash & Equivalents over the past 13 years, most recently at $162.5 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $162.5 million for Q4 2025, down 66.31% from a year ago — trailing twelve months through Dec 2025 was $162.5 million (down 66.31% YoY), and the annual figure for FY2025 was $398.1 million, down 0.93%.
  • Cash & Equivalents for Q4 2025 was $162.5 million at Paylocity Holding, down from $165.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PCTY hit a ceiling of $778.5 million in Q3 2024 and a floor of $65.5 million in Q3 2022.
  • Median Cash & Equivalents over the past 5 years was $218.0 million (2021), compared with a mean of $275.2 million.
  • Biggest five-year swings in Cash & Equivalents: soared 365.81% in 2023 and later tumbled 78.78% in 2025.
  • Paylocity Holding's Cash & Equivalents stood at $84.1 million in 2021, then soared by 42.74% to $120.1 million in 2022, then soared by 205.62% to $366.9 million in 2023, then soared by 31.47% to $482.4 million in 2024, then crashed by 66.31% to $162.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $162.5 million (Q4 2025), $165.2 million (Q3 2025), and $398.1 million (Q2 2025) per Business Quant data.